Refine by
Immunosuppression Suppliers & Manufacturers
58 companies found
based inVictoria, BRITISH COLUMBIA (CANADA)
Established in 2007, StressMarq Biosciences is a bioreagents company producing high quality, cutting edge research products for the life sciences and drug discovery/biopharma markets. StressMarq is a market leader in the development and ...
Product Name: mTOR Antibody (pSer2448). Description: Rabbit Anti-Human mTOR (pSer2448) Polyclonal. Species Reactivity: Human, Mouse, Rat. Applications: WB, IHC. Antibody Dilution: WB (1:250-1:1000); IHC (1:25-1:100); optimal dilutions for assays ...
based inParis, FRANCE
Enterome is pioneering the discovery and development of novel pharmaceuticals based on its unrivalled understanding of the interaction between the gut microbiome and the immune system – the Microbiome-Immunoinflammation Axis. Enterome is using this ...
based inBryan, TEXAS (USA)
At iBio, we are using our RubrYc® Discovery Platform to tackle complex and challenging drug targets, with the goal of developing safer and more effective immunotherapies for difficult-to-treat cancers. We envision a world where drug discovery is ...
The Treg is a type of T cell that is important in preventing autoimmunity by keeping effector T cells [Teffs] “in-check” to prevent destruction of healthy tissues. However, around tumors, Tregs create an ...
based inRedmond, WASHINGTON (USA)
SystImmune Inc. is a biopharmaceutical company focused on the treatment of cancer through developing novel therapeutic bi-specific, and multi-specific antibodies, as well as antibody-drug conjugates (ADCs). Our objective is to create biologics that ...
Guidance and Navigation Control (GNC) molecules are multi-specific cell engager proteins. GNC in the oncology therapeutics class bind to cancer cells and to immune cells and stimulate the immune cell cancer killing activity. By design, each GNC ...
based inSouth San Francisco, CALIFORNIA (USA)
Veracyte is a pioneering genomic diagnostics company. Our tests provide trustworthy and actionable ANSWERS that improve care throughout the patient journey. We ask the right questions and provide answers that give physicians and patients a clearer ...
Increasing confidence in ILD diagnosis and prognosis. The Envisia Genomic Classifier is the first commercially available genomic test to improve physicians’ ability to differentiate IPF from other interstitial lung diseases (ILD) without the ...
based inRapperswil, SWITZERLAND
Neovii is an independent, global biopharmaceutical company with a patient-focused mission to develop and bring to market novel life-transforming therapies to improve the outcomes in transplantation medicine, hemato-oncological and immune disorders. ...
Organ transplantation is a lifesaving procedure for end-stage organ failure. Solid-organ transplantation involves replacing the diseased or failing organ with a new, healthy one. Commonly transplanted organs are the kidney, liver, heart, and ...
based inMunich, GERMANY
multimmune GmbH is a private, clinical-stage biopharmaceutical company which has developed a unique and proprietary technology platform for the development and clinical delivery of new cancer therapies on the basis of the founding scientists' ...
mi-APO is a targeted protein product with potential to be used for the treatment of most tumor types. The product targets surface-bound heat shock protein 70 (Hsp70). Surface-bound Hsp70 is a tumor-specific marker expressed on about 50-75% of ...
based inTokyo, JAPAN
Healios will expand the possibilities for curing diseases to increase and further enrich quality of life through the development and supply of regenerative medicine products as part of the rapid progress of regenerative medicine taking place in the ...
Somatic stem cell regenerative medicine utilizes somatic stem cells, which are present in various tissues of the body, with the aim of developing new treatments for diseases for which the current standard of care may be limited or unavailable to ...
based inLublin, POLAND
We are a Polish biotechnology company with long manufacturing traditions. We have been present on the Polish and international markets since 1944. We are challenged and truly honoured to provide the leading, innovative medical solutions, and, due to ...
based inTuebingen, GERMANY
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation ...
ACTallo® is a process developed by Immatics for the manufacture of allogeneic, off-the-shelf, TCR-engineered cellular therapies derived from healthy donors’ gamma delta T ...
based inSan Diego, CALIFORNIA (USA)
Stemedica Cell Technologies, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of progenitor cell and protein therapeutics for underserved medical conditions. Stemedica has developed a proprietary ...
itMSCs (ischemia-tolerant mesenchymal stem cells) are “trophic” cells that circulate throughout the body and release proteins and growth factors into the damaged tissue, rescuing damaged cells from death and creating the right conditions ...
based in, MASSACHUSETTS (USA)
Thermo Scientific instruments, equipment, software, services and consumables empower scientists to solve for complex analytical challenges in pharmaceutical, biotechnology, academic, government, environmental and industrial research, as well as the ...
Experience an uncompromised level of performance and ease of use with the Thermo Scientific™ Indiko™ Plus Clinical Chemistry Analyzer. This fully-automated random access benchtop system for clinical and specialty chemistry testing, ...
based inWürzburg, GERMANY
Toleris Biotherapeutics GmbH is a biotechnology company based in Würzburg, Germany. The company specializes in the development of innovative biotherapeutic solutions aiming to advance the field of medicine through cutting-edge scientific research. ...
By leveraging optimized soluble versions of the non-classical MHC Ib molecule HLA-G, AIM Biologicals can accumulate in lymph nodes to induce regulatory CD8+ T cells that protect tissues presenting autoantigens attacked in autoimmune diseases. This ...
based inParís, FRANCE
Biogen Technologies S.L. is a recognized leader in sustainable water hygiene solutions. Its portfolio includes a diverse range of advanced filtering systems designed for medical applications, including endpoint tap and shower filters, as well as ...
based inNewtown, AUSTRALIA
Genetic Signatures was founded in 2001 by the late Dr. Geoffrey Grigg. We are the developers of 3base technology which is the cornerstone of our EasyScreen Pathogen Detection Kits. Our proprietary technology provides hospital and pathology ...
In the United States (US), gastrointestinal (GI) protozoan parasites are a significant healthcare burden, with more than 350 million cases of acute GI infections annually. Globally, protozoan infections are the leading cause of mortality of children ...
based inPhiladelphia, PENNSYLVANIA (USA)
A clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases Cabaletta Bio seeks to employ its specifically targeted CAAR (Chimeric AutoAntibody Receptor) T ...
Our lead product candidate, DSG3-CAART, is being developed to treat mucosal pemphigus vulgaris (mPV), a blistering skin disease that affects mucous membranes. mPV is caused by autoantibodies that attack the cell adhesion protein desmoglein 3, or ...
based inBasel, SWITZERLAND
CanVirex is a spin-off from the Heidelberg University Hospital, founded in 2017 in Basel, Switzerland. The company develops novel immunotherapeutics for the treatment of cancer and has recently committed to using its unique technology to develop a ...
Oncolytic measles viruses as a multiplexed immune-modulating platform for cancer therapy. Cancer remains a medical and social burden worldwide despite several technological advances in the past decades. Conventional cancer treatments such as ...
based inCambridge, MASSACHUSETTS (USA)
Seres Therapeutics is a late-clinical stage biotechnology company with a strong development pipeline and rigorous scientific underpinning, working to revolutionize treatment of a wide range of diseases by modulating the function of the human ...
SER-155 is an investigational, oral, rationally designed, fermented microbiome therapeutic designed to reduce the incidence of gastrointestinal infections, bacteremia, and graft versus host disease (GvHD) in immunocompromised patients, including ...
based inHOLLOLA, FINLAND
Porkka Finland specializes in the design and manufacturing of high-quality professional refrigeration equipment and custom cold and clean room solutions, catering to various industrial sectors including HoReCa, medical, and research fields. With ...
The ice cubes are produced using a spray system that minimizes water and power consumption, resulting in clear and hard ice cubes ideal for patient comfort, particularly for immunosuppressed individuals. The ice flakes are generated ...
based inValencia, CALIFORNIA (USA)
SetPoint Medical, headquartered in Valencia, Ca., is a privately-held clinical-stage bioelectronic medicine company dedicated to treating patients with chronic autoimmune diseases. The company is pioneering a new treatment paradigm, using electrical ...
The SetPoint Medical bioelectronic medicine platform delivers targeted electrical pulses to trigger the intrinsic inflammatory reflex. This pathway shows promise as an alternative, efficient treatment option for rheumatoid arthritis (RA), ...